非编码RNA在阿尔茨海默病病理生理学中的作用
Edward O Olufunmilayo1,2, R M Damian Holsinger1,3
1Laboratory of Molecular Neuroscience and Dementia, School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW 2050, Australia.
International journal of molecular sciences
|August 12, 2023
概括
阿尔茨海默病涉及粉样β斑块和团. 本综述探讨了像微RNA这样的非编码RNA (ncRNA) 是如何参与的,为阿尔茨海默病提供了潜在的生物标志物和治疗点.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 遗传学 是一个
- 分子生物学分子生物学
背景情况:
- 阿尔茨海默病 (AD) 是一种神经退行性疾病,其特征是记忆和认知缺陷.
- 在病理上,AD的特点是粉样β斑块和神经纤维状,导致神经炎症和突触功能障碍.
- 阿尔茨海默病是一种复杂,多方面的疾病,受遗传,表观遗传,行为和环境因素的影响.
研究的目的:
- 审查有关阿尔茨海默病非编码RNAs (ncRNAs) 的当前发现.
- 要突出循环RNA (circRNA),微RNA (miRNA),短干扰RNA (siRNA),piwi相互作用RNA (piRNA) 和长非编码RNA (lncRNA) 在AD中的作用.
- 讨论ncRNAs作为AD生物标志物和治疗点的潜力.
主要方法:
- 对研究研究阿尔茨海默病中ncRNAs的文献综述.
- 对导致AD病变的遗传和表观遗传因素的研究分析.
- 检查了针对细胞和动物AD模型中的ncRNAs的研究.
主要成果:
- 在阿尔茨海默病中观察到各种ncRNA (circRNA,miRNA,siRNA,piRNA,lncRNA) 的显著变化.
- 这些ncRNA变异与AD发病和进展机制有关.
- 在临床前模型中准ncRNA的研究显示出治疗开发的前景.
结论:
- 非编码RNAs代表了阿尔茨海默病研究的关键领域.
- 失调的ncRNA具有作为AD诊断生物标志物和治疗点的潜力.
- 对ncRNA机制的进一步研究可能会导致阿尔茨海默病的新疗法.
相关概念视频
01:26Alzheimer's Disease: Overview
521
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
521
01:20Types of RNA
5.9K
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
RNA Performs Diverse...
5.9K
01:22Alzheimer's Disease: Treatment
215
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
215
02:39lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
02:30siRNA - Small Interfering RNAs
16.8K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.8K
02:23RNA Editing
9.0K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
9.0K